Rep. Stupak Works To Increase FDA Oversight, Improve Prescription Drug Safety
Friday, February 22nd, 2008The Wall Street Journal on Wednesday examined House Energy and Commerce Oversight and Investigations Subcommittee Chair Bark Stupak's (D-Mich.) efforts to increase FDA oversight and improve the safety of prescription drugs. According to the Journal, Stupak is "at the center of an aggressive effort by congressional Democrats to spotlight what ...